AAAAAA
Results:
1-23
|
Results: 23
Authors:
Kolsch, H
Ptok, U
Bagli, M
Papassotiropoulos, A
Schmitz, S
Barkow, K
Kockler, M
Rao, ML
Maier, W
Heun, R
Citation: H. Kolsch et al., Gene polymorphisms of interleukin-1 alpha influence the course of Alzheimer's disease, ANN NEUROL, 49(6), 2001, pp. 818-819
Authors:
de la Torre, BR
Dreher, J
Malevany, L
Bagli, M
Kolbinger, M
Omran, H
Luderitz, B
Rao, ML
Citation: Br. De La Torre et al., Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients, THER DRUG M, 23(4), 2001, pp. 435-440
Influence of CYP2D6 genotype and medication on the sparteine metabolic ratio of psychiatric patients
Authors:
Lohmann, PL
Rao, ML
Ludwig, M
Griese, EU
Zanger, UM
Morike, K
Maier, W
Bagli, M
Citation: Pl. Lohmann et al., Influence of CYP2D6 genotype and medication on the sparteine metabolic ratio of psychiatric patients, EUR J CL PH, 57(4), 2001, pp. 289-295
Authors:
Papassotiropoulos, A
Bagli, M
Jessen, F
Maier, W
Forstl, H
Kurz, A
Heun, R
Citation: A. Papassotiropoulos et al., Interaction of two genes possibly involved in the regulation of the amyloid precursor protein (APP) processing, MOL PSYCHI, 5(3), 2000, pp. 240-241
Authors:
Papassotiropoulos, A
Bagli, M
Jessen, F
Frahnert, C
Rao, ML
Maier, W
Heun, R
Citation: A. Papassotiropoulos et al., Confirmation of the association between bleomycin hydrolase genotype and Alzheimer's disease, MOL PSYCHI, 5(2), 2000, pp. 213-215
Authors:
Papassotiropoulos, A
Bagli, M
Becker, K
Jessen, F
Maier, W
Rao, ML
Ludwig, M
Heun, R
Citation: A. Papassotiropoulos et al., No association between an intronic biallelic polymorphism of the FE65 geneand Alzheimer's disease, INT J MOL M, 6(5), 2000, pp. 587-589
Authors:
Papassotiropoulos, A
Lutjohann, D
Bagli, M
Locatelli, S
Jessen, F
Rao, ML
Maier, W
Bjorkhem, I
von Bergmann, K
Heun, R
Citation: A. Papassotiropoulos et al., Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease, NEUROREPORT, 11(9), 2000, pp. 1959-1962
Authors:
Weigmann, H
Hartter, S
Bagli, M
Hiemke, C
Citation: H. Weigmann et al., Steady state concentrations of clomipramine and its major metabolite desmethylclomipramine in rat brain and serum after oral administration of clomipramine, EUR NEUROPS, 10(5), 2000, pp. 401-405
Authors:
Papassotiropoulos, A
Bagli, M
Kurz, A
Kornhuber, J
Forstl, H
Maier, W
Pauls, J
Lautenschlager, N
Heun, R
Citation: A. Papassotiropoulos et al., A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease, ANN NEUROL, 47(3), 2000, pp. 399-403
Authors:
Bagli, M
Papassotiropoulos, A
Jessen, F
Rao, ML
Maier, W
Heun, R
Citation: M. Bagli et al., Gene-gene interaction between interleukin-6 and alpha(2)-Macroglobulin influences the risk for Alzheimer's disease, ANN NEUROL, 47(1), 2000, pp. 138-139
Authors:
Schmidt, S
Papassotiropoulos, A
Bagli, M
Harzheim, M
Heun, R
Klockgether, T
Citation: S. Schmidt et al., No association of serum levels of interleukin-6 and its soluble receptor components with a genetic variation in the 3 ' flanking region of the interleukin-6 gene in patients with multiple sclerosis, NEUROSCI L, 294(3), 2000, pp. 139-142
Authors:
Majores, M
Bagli, M
Papassotiropoulos, A
Schwab, SG
Jessen, F
Rao, ML
Maier, W
Heun, R
Citation: M. Majores et al., Allelic association between the D10S1423 marker and Alzheimer's disease ina German population, NEUROSCI L, 289(3), 2000, pp. 224-226
Authors:
Bagli, M
Papassotiropoulos, A
Knapp, M
Jessen, F
Rao, ML
Maier, W
Heun, R
Citation: M. Bagli et al., Association between an interleukin-6 promoter and 3 ' flanking region haplotype and reduced Alzheimer's disease risk in a German population, NEUROSCI L, 283(2), 2000, pp. 109-112
Authors:
Bagli, M
Papassotiropoulos, A
Jessen, F
Schmitz, S
Rao, ML
Maier, W
Heun, R
Citation: M. Bagli et al., Identical distribution of the alpha 2-macroglobulin pentanucleotide deletion in subjects with Alzheimer disease and controls in a German population, AM J MED G, 96(6), 2000, pp. 775-777
Authors:
Lutjohann, D
Papassotiropoulos, A
Bjorkhem, I
Locatelli, S
Bagli, M
Oehring, RD
Schlegel, U
Jessen, F
Rao, ML
von Bergmann, K
Heun, R
Citation: D. Lutjohann et al., Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients, J LIPID RES, 41(2), 2000, pp. 195-198
Authors:
Schwab, SG
Bagli, M
Papassotiropoulos, A
Jessen, F
Maier, W
Rao, ML
Heun, R
Citation: Sg. Schwab et al., Alpha-1-antichymotrypsin gene polymorphism and risk for sporadic Alzheimer's disease in a German population, DEMENT G C, 10(6), 1999, pp. 469-472
Authors:
Papassotiropoulos, A
Bagli, M
Jessen, F
Rao, ML
Schwab, SG
Heun, R
Citation: A. Papassotiropoulos et al., Early-onset and late-onset depression are independent of the genetic polymorphism of apolipoprotein E, DEMENT G C, 10(4), 1999, pp. 258-261
Authors:
Wegerer, V
Moll, GH
Bagli, M
Rothenberger, A
Ruther, E
Huether, G
Citation: V. Wegerer et al., Persistently increased density of serotonin transporters in the frontal cortex of rats treated with fluoxetine during early juvenile life, J CH AD PSY, 9(1), 1999, pp. 13-24
Authors:
Dreher, J
Kolbinger, M
de la Torre, BR
Bagli, M
Malevanyi, J
Rao, ML
Citation: J. Dreher et al., A novel self-rating scale for adverse drug effects and its application to antidepressant drug treatment, F NEUR PSYC, 67(4), 1999, pp. 163-174
Authors:
Papassotiropoulos, A
Bagli, M
Jessen, F
Bayer, TA
Maier, W
Rao, ML
Heun, R
Citation: A. Papassotiropoulos et al., A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease, ANN NEUROL, 45(5), 1999, pp. 666-668
Authors:
Papassotiropoulos, A
Bagli, M
Feder, O
Jessen, F
Maier, G
Rao, ML
Ludwig, M
Schwab, SG
Heun, R
Citation: A. Papassotiropoulos et al., Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease, NEUROSCI L, 262(3), 1999, pp. 171-174
Authors:
Bagli, M
Papassotiropoulos, A
Schwab, SG
Jessen, F
Rao, ML
Maier, W
Heun, R
Citation: M. Bagli et al., No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer disease in a German population, J NEUR SCI, 167(1), 1999, pp. 34-36
Authors:
Bagli, M
Suverkrup, R
Quadflieg, R
Hoflich, G
Kasper, S
Moller, HJ
Langer, M
Barlage, U
Rao, ML
Citation: M. Bagli et al., Pharmacokinetic-pharmacodynamic modeling of tolerance to the prolactin-secreting effect of chlorprothixene after different modes of drug administration, J PHARM EXP, 291(2), 1999, pp. 547-554
Risultati:
1-23
|